Pg. Andreis et al., Effects of irbesartan and bosentan on the blood pressure and adrenal zona glomerulosa function in heterozygous transgenic TGR[mREN2]27 rats, LIFE SCI, 67(5), 2000, pp. 543-547
The role of angiotensin-II (Ang-II) and endothelin-1 (ET-1) in the developm
ent of hypertension and zona glomerulosa (ZG) hyperfunction in the transgen
ic rat strain TGR[mREN2]27 (TGR) has been investigated. Male heterozygous T
GR were given per os for 4 weeks the Ang-II AT1 receptor antagonist irbesar
tan (50 mg/kg day) or the mixed ETA/ETB receptor antagonist bosentan (100 m
g/kg day), A group of TGR received a placebo gavage. Irbesartan lowered blo
od pressure (BP), while bosentan was ineffective. Conversely, both antagoni
sts decreased plasma aldosterone concentration, the volume of ZG and its pa
renchymal cells, and in vitro aldosterone secretion by capsule-ZG preparati
ons. Collectively, our results allow us to conclude that (i) only Ang-II is
involved in the genesis of hypertension in TGR, while both endogenous Ang-
II and ET-1 play a role in the genesis of ZG hyperfunction; and (ii) hypera
ldosteronism does not contribute significantly to the development of hypert
ension in TGR. (C) 2000 Elsevier Science Inc. All rights reserved.